Ilarja Serini Šeremet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ilarja Serini Šeremet has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Ivona Butorac Ahel
Clinical Hospital Center Rijeka
1 shared publication - Kristina Lah Tomulić
Klinički bolnički centar Rijeka, Medicinski fakultet Sveučilišta u Rijeci
1 shared publication
Latest Publications
- Open Access
- 1 June 2026
- Published by Croatian Medical Association in Paediatria Croatica
- Vol. 70 (2) , 125-8
Insulin degludec-related suicide attempt in a non-diabetic adolescent: a case report
Aim: Although insulin is considered a life-saving medication for patients with type 1 diabetes and some patients with type 2 diabetes, there are instances where it is used in suicide attempts. It can cause refractory and prolonged hypoglycemia, which can be challenging for clinicians. Case presentation: We present a case of a 16-year-old non-diabetic patient who attempted suicide with long-acting insulin degludec and presented with life-threatening hypoglycemia. Conclusion: Exogenous insulin administration should be suspected in severe, unexplained hypoglycemia. The interpretation of insulin and C-peptide levels is a crucial diagnostic component in confirming exogenous insulin administration.
- 1 June 2026
- Published by Croatian Medical Association in Paediatria Croatica
- Vol. 70 (2) , 125-8
Open AccessInsulin degludec-related suicide attempt in a non-diabetic adolescent: a case report
Aim: Although insulin is considered a life-saving medication for patients with type 1 diabetes and some patients with type 2 diabetes, there are instances where it is used in suicide attempts. It can cause refractory and prolonged hypoglycemia, which can be challenging for clinicians. Case presentation: We present a case of a 16-year-old non-diabetic patient who attempted suicide with long-acting insulin degludec and presented with life-threatening hypoglycemia. Conclusion: Exogenous insulin administration should be suspected in severe, unexplained hypoglycemia. The interpretation of insulin and C-peptide levels is a crucial diagnostic component in confirming exogenous insulin administration.